Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1970 Oct;2(4):404–413. doi: 10.1128/iai.2.4.404-413.1970

Experimental Cerebral Zygomycosis in Alloxan-Diabetic Rabbits I. Relationship of Temperature Tolerance of Selected Zygomycetes to Pathogenicity

Donald J Reinhardt a,1, William Kaplan a, Libero Ajello a
PMCID: PMC416024  PMID: 16557853

Abstract

Acute alloxan diabetic rabbits were used in a survey of the potential ability of Absidia, Cunninghamella, Mucor, Rhizopus, Syncephalastrum, and Thamnidium species to cause cerebral zygomycosis (phycomycosis, mucormycosis). Specifically, the correlation of thermotolerance with potential pathogenicity was studied. The test organisms fell into two groups: those able to grow well at 39 C on Sabouraud dextrose agar and those unable to grow at that temperature. Isolates unable to grow at 39 C were not pathogenic. The nonpathogens were C. elegans, M. jansenni, R. reflexus, R. stolonifer, and T. elegans. Two isolates of S. racemosum and one isolate of A. corymbifera, although able to grow well at 39 C in vitro, did not invade the brain or lungs of acutely diabetic rabbits. Three species of Rhizopus, R. chinensis, R. microsporus, and R. oligosporus, all of which grew at 39 C and which had not been previously known to cause cerebral zygomycosis, were as pathogenic as the only two previously implicated disease agents, R. arrhizus and R. oryzae. Studies were also carried out to determine whether animals inoculated with spores of selected zygomycetes many hours prior to the onset of acute diabetes would develop cerebral zygomycosis. Approximately 50% of the rabbits that became acutely diabetic 72 to 90 hr after receiving R. oryzae spores by nasal instillation succumbed to cerebral zygomycosis. Our study indicates that several members of the genus Rhizopus that grow well at 39 C or higher, other than R. arrhizus and R. oryzae, are potential etiological agents of cerebral zygomycosis.

Full text

PDF
404

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKER R. D., BASSERT D. E., FERRINGTON E. Mucormycosis of the digestive tract. AMA Arch Pathol. 1957 Feb;63(2):176–182. [PubMed] [Google Scholar]
  2. BAUER H., AJELLO L., ADAMS E., HERNANDEZ D. U. Cerebral mucormycosis: pathogenesis of the disease; description of the fungus, Rhizopus oryzae, isolated from a fatal case. Am J Med. 1955 May;18(5):822–831. doi: 10.1016/0002-9343(55)90194-7. [DOI] [PubMed] [Google Scholar]
  3. BAUER H., FLANAGAN J. F., SHELDON W. H. Experimental cerebral mucormycosis in rabbits with alloxan diabetes. Yale J Biol Med. 1955 Sep;28(1):29–36. [PMC free article] [PubMed] [Google Scholar]
  4. BAUER H., FLANAGAN J. F., SHELDON W. H. The effects of metabolic alterations on experimental Rhizopus oryzae (mucormycosis) infection. Yale J Biol Med. 1956 Sep;29(1):23–32. [PMC free article] [PubMed] [Google Scholar]
  5. BURROW G. N., SALMON R. B., NOLAN J. P. Successful treatment of cerebral mucormycosis with amphotericin B. JAMA. 1963 Feb 2;183:370–372. doi: 10.1001/jama.1963.63700050034023a. [DOI] [PubMed] [Google Scholar]
  6. CRUICKSHANK A. H. Liver necrosis and alloxan hypoglycaemia. J Pathol Bacteriol. 1954 Jan;67(1):227–236. doi: 10.1002/path.1700670127. [DOI] [PubMed] [Google Scholar]
  7. ELDER T. D., BAKER R. D. Pulmonary mucormycosis in rabbits with alloxan diabetes; increased invasiveness of fungus during acute toxic phase of diabetes. AMA Arch Pathol. 1956 Feb;61(2):159–168. [PubMed] [Google Scholar]
  8. Greer D. L., Friedman L. Antigenic relationships between the fungus causing subcutaneous phycomycosis and saprophytic isolates of Basidiobolus meristosporus and B. ranarum. Sabouraudia. 1966 Jun;5(1):7–13. doi: 10.1080/00362176785190031. [DOI] [PubMed] [Google Scholar]
  9. Greer D. L., Friedman L. Studies on the genus Basidiobolus with reclassification of the species pathogenic for man. Sabouraudia. 1966 Feb;4(4):231–241. [PubMed] [Google Scholar]
  10. HESSELTINE C. W. A survey of the mucorales. Trans N Y Acad Sci. 1952 Mar;14(5):210–214. doi: 10.1111/j.2164-0947.1952.tb01102.x. [DOI] [PubMed] [Google Scholar]
  11. HOAGLAND R. J., SUBE J., BISHOP R. H., Jr, HOLDING B. F., Jr Mucormycosis. Am J Med Sci. 1961 Oct;242:415–422. doi: 10.1097/00000441-196110000-00003. [DOI] [PubMed] [Google Scholar]
  12. KIAN JOE L., POHAN A., TJOEI ENG N. I., VAN DER MEULEN H. Basidiobolus ranarum as a cause of subcutaneous mycosis in Indonesia. AMA Arch Derm. 1956 Oct;74(4):378–383. doi: 10.1001/archderm.1956.01550100046008. [DOI] [PubMed] [Google Scholar]
  13. LANDMAN O. E., BAUSUM H. T., MATNEY T. S. Temperaturegradient plates for growth of microorganisms. J Bacteriol. 1962 Mar;83:463–469. doi: 10.1128/jb.83.3.463-469.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Martinson F. D., Clark B. M. Rhinophycomycosis entomophthorae in Nigeria. Am J Trop Med Hyg. 1967 Jan;16(1):40–47. doi: 10.4269/ajtmh.1967.16.40. [DOI] [PubMed] [Google Scholar]
  15. NEAME P., RAYNER D. Mucormycosis. A report on twenty-two cases. Arch Pathol. 1960 Aug;70:261–268. [PubMed] [Google Scholar]
  16. Wang H. L., Hesseltine C. W. Studies on the extracellular proteolytic enzymes of Rhizopus oligosporus. Can J Microbiol. 1965 Aug;11(4):727–732. doi: 10.1139/m65-096. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES